OpenLB
Open Library of Bioscience
Advanced Search
Microorganisms
Feb 12, 2019;7 (2):

PES Pathogens in Severe Community-Acquired Pneumonia.

Catia Cillóniz, Cristina Dominedò, Antonello Nicolini, Antoni Torres
Author Information
  1. Catia Cillóniz: Department of Pneumology, Hospital Clinic of Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona (UB)-SGR 911-Ciber de Enfermedades Respiratorias (Ciberes), 08036 Barcelona, Spain. catiacilloniz@yahoo.com. ORCID
  2. Cristina Dominedò: Department of Anesthesiology and Intensive Care Medicine, Fondazione Policlinico Universitario A. Gemelli, Università Cattolica del Sacro Cuore, 00168 Rome, Italy. c.dominedo1@alice.it. ORCID
  3. Antonello Nicolini: Respiratory Diseases Unit, Hospital of Sestri Levante, 16039 Sestri Levante, Italy. antonellonicolini@gmail.com. ORCID
  4. Antoni Torres: Department of Pneumology, Hospital Clinic of Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona (UB)-SGR 911-Ciber de Enfermedades Respiratorias (Ciberes), 08036 Barcelona, Spain. atorres@clinic.cat.
PMID: 30759805 DOI: 10.3390/microorganisms7020049

Abstract

Worldwide, there is growing concern about the burden of pneumonia. Severe community-acquired pneumonia (CAP) is frequently complicated by pulmonary and extra-pulmonary complications, including sepsis, septic shock, acute respiratory distress syndrome, and acute cardiac events, resulting in significantly increased intensive care admission rates and mortality rates. (Pneumococcus) remains the most common causative pathogen in CAP. However, several bacteria and respiratory viruses are responsible, and approximately 6% of cases are due to the so-called PES (, extended-spectrum β-lactamase , and methicillin-resistant ) pathogens. Of these, and methicillin-resistant are the most frequently reported and require different antibiotic therapy to that for typical CAP. It is therefore important to recognize the risk factors for these pathogens to improve the outcomes in patients with CAP.

Keywords

PES pathogens community-acquired pneumonia pneumonia severe pneumonia

References

  1. Antimicrob Agents Chemother. 2001 Mar;45(3):825-36 [PMID: 11181368]
  2. Intensive Care Med. 2004 Apr;30(4):536-55 [PMID: 14997291]
  3. Clin Infect Dis. 2007 Mar 1;44 Suppl 2:S27-72 [PMID: 17278083]
  4. Crit Care. 2009;13(2):R45 [PMID: 19335921]
  5. Infect Dis Clin North Am. 2009 Sep;23(3):535-56 [PMID: 19665082]
  6. Thorax. 2009 Oct;64 Suppl 3:iii1-55 [PMID: 19783532]
  7. Crit Care. 2010;14(1):R2 [PMID: 20064197]
  8. Crit Care. 2011;15(1):R36 [PMID: 21261976]
  9. J Antimicrob Chemother. 2011 Apr;66 Suppl 3:iii19-32 [PMID: 21482566]
  10. J Antimicrob Chemother. 2011 Apr;66 Suppl 3:iii33-44 [PMID: 21482568]
  11. Clin Microbiol Infect. 2012 Mar;18(3):268-81 [PMID: 21793988]
  12. Clin Infect Dis. 2012 Feb 15;54(4):470-8 [PMID: 22109954]
  13. Arch Gerontol Geriatr. 2012 Mar-Apr;54(2):e193-8 [PMID: 22178584]
  14. Int J Antimicrob Agents. 2012 Mar;39(3):240-6 [PMID: 22230331]
  15. Chest. 2012 Jun;141(6):1393-1399 [PMID: 22670019]
  16. JAMA. 2012 Jun 20;307(23):2526-33 [PMID: 22797452]
  17. Acta Anaesthesiol Scand. 2012 Nov;56(10):1298-305 [PMID: 23016991]
  18. BMC Infect Dis. 2013 Apr 30;13:196 [PMID: 23631630]
  19. BMC Infect Dis. 2013 Jun 06;13:268 [PMID: 23742753]
  20. Thorax. 2013 Nov;68(11):997-9 [PMID: 23774884]
  21. Chest. 2014 Jul;146(1):22-31 [PMID: 24371840]
  22. JAMA Intern Med. 2014 Dec;174(12):1894-901 [PMID: 25286173]
  23. Ann Am Thorac Soc. 2015 Feb;12(2):153-60 [PMID: 25521229]
  24. Thorax. 2015 Jun;70(6):551-8 [PMID: 25782758]
  25. N Engl J Med. 2015 Apr 2;372(14):1312-23 [PMID: 25830421]
  26. PLoS One. 2015 Apr 10;10(4):e0119528 [PMID: 25860142]
  27. Lancet Infect Dis. 2015 May;15(5):581-614 [PMID: 25932591]
  28. N Engl J Med. 2015 Jul 30;373(5):415-27 [PMID: 26172429]
  29. Am J Respir Crit Care Med. 2016 Feb 1;193(3):259-72 [PMID: 26414292]
  30. Crit Care. 2015 Sep 30;19:353 [PMID: 26423744]
  31. PLoS One. 2016 Jan 04;11(1):e0145929 [PMID: 26727202]
  32. Antimicrob Agents Chemother. 2016 Apr 22;60(5):2652-63 [PMID: 26856838]
  33. J Infect Chemother. 2017 Jan;23(1):23-28 [PMID: 27729192]
  34. JAMA. 2016 Dec 20;316(23):2547-2548 [PMID: 27792809]
  35. J Korean Med Sci. 2017 Jan;32(1):77-84 [PMID: 27914135]
  36. Intensive Care Med. 2017 Sep;43(9):1319-1328 [PMID: 28238055]
  37. Infect Dis Clin North Am. 2017 Sep;31(3):415-434 [PMID: 28687212]
  38. PLoS One. 2018 Jan 25;13(1):e0191721 [PMID: 29370285]
  39. Eur Respir J. 2018 Mar 29;51(3): [PMID: 29545274]
  40. Eur Respir J. 2018 Aug 9;52(2): [PMID: 29976651]
  41. Clin Infect Dis. 2018 Aug 1;:null [PMID: 30084884]
  42. Ann Intensive Care. 2018 Aug 15;8(1):84 [PMID: 30112650]
  43. J Crit Care. 2018 Dec;48:479 [PMID: 30126747]
  44. J Crit Care. 2019 Feb;49:84-91 [PMID: 30388493]
  45. Lancet Infect Dis. 2019 Jan;19(1):56-66 [PMID: 30409683]
  46. Chest. 2018 Nov 22;:null [PMID: 30471269]
Journal Article Review
Article has an altmetric score of 12

Word Cloud

Created with Highcharts 10.0.0pneumoniaCAPPESpathogensSeverecommunity-acquiredfrequentlyacuterespiratoryratesmethicillin-resistantWorldwidegrowingconcernburdencomplicatedpulmonaryextra-pulmonarycomplicationsincludingsepsissepticshockdistresssyndromecardiaceventsresultingsignificantlyincreasedintensivecareadmissionmortalityPneumococcusremainscommoncausativepathogenHoweverseveralbacteriavirusesresponsibleapproximately6%casesdueso-calledextended-spectrumβ-lactamasereportedrequiredifferentantibiotictherapytypicalthereforeimportantrecognizeriskfactorsimproveoutcomespatientsPathogensCommunity-AcquiredPneumoniasevere

Similar Articles

Cited By